Among them, β-elemene enhanced cisplatin activity by causing lung cancer cell death, which was regulated by the CHK2-mediated cdc25C/cdc2/cyclin B1 signaling pathway to block cell cycle progression at G2/M phase [64]. The gene discussed is CDK1; the disease is lung cancer.